Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation
Authors:
- Louis MatzaLMLouis Matza
- PhillipsPHPhillips
- RevickiRERevicki
- FariesFAFaries
Open Access
- 1 July 2012
- journal article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 6, 521-32
Abstract
Peer reviewed article authored by (Matza LS, Phillips GA, Revicki DA, Ascher-Svanum H, Malley KG, Palsgrove AC, Faries DE, Stauffer V, Kinon BJ, Awad AG, Keefe RS, Naber D). Read article or submit your manuscript for publishing.Keywords
This publication has 22 references indexed in Scilit:
- Development of a clinician questionnaire and patient interview to assess reasons for antipsychotic discontinuationPsychiatry Research, 2011
- Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectivesCurrent Medical Research and Opinion, 2010
- Comparison of Patient and Clinician Perspectives in the Assessment of Antipsychotic Medication AdherencePsychopathology, 2009
- The Temporal Relationship Between Symptom Change and Treatment Discontinuation in a Pooled Analysis of 4 Schizophrenia TrialsJournal of Clinical Psychopharmacology, 2008
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trialThe Lancet, 2008
- What does the PANSS mean?Schizophrenia Research, 2005
- Effectiveness of Antipsychotic Drugs in Patients with Chronic SchizophreniaNew England Journal of Medicine, 2005
- Application of Structural Equation Modeling to Health Outcomes ResearchEvaluation & the Health Professions, 2005
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987
- Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit.Psychological Bulletin, 1968